Published in Eur J Endocrinol on October 01, 1997
Growth hormone induces hepatic production of fibroblast growth factor 21 through a mechanism dependent on lipolysis in adipocytes. J Biol Chem (2011) 1.20
Mutation analysis of the muscarinic cholinergic receptor genes in isolated growth hormone deficiency type IB. J Clin Endocrinol Metab (2009) 0.77
Cholinergic function and neural control of GH secretion. A critical re-appraisal. Eur J Endocrinol (1997) 0.75
Cluster analysis: a simple, versatile, and robust algorithm for endocrine pulse detection. Am J Physiol (1986) 2.94
Transdermal testosterone gel improves sexual function, mood, muscle strength, and body composition parameters in hypogonadal men. J Clin Endocrinol Metab (2000) 2.68
Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human. Endocr Rev (1998) 2.39
Saltation and stasis: a model of human growth. Science (1992) 2.28
Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: relation to hypercortisolism and corticotropin-releasing hormone. Proc Natl Acad Sci U S A (2000) 2.19
Long-term pharmacokinetics of transdermal testosterone gel in hypogonadal men. J Clin Endocrinol Metab (2000) 1.99
Age and relative adiposity are specific negative determinants of the frequency and amplitude of growth hormone (GH) secretory bursts and the half-life of endogenous GH in healthy men. J Clin Endocrinol Metab (1991) 1.84
Older males secrete luteinizing hormone and testosterone more irregularly, and jointly more asynchronously, than younger males. Proc Natl Acad Sci U S A (1996) 1.79
Attenuation of luteinizing hormone secretory burst amplitude as a proximate basis for the hypoandrogenism of healthy aging in men. J Clin Endocrinol Metab (1992) 1.76
Greater secretion of growth hormone in black than in white men: possible factor in greater bone mineral density--a clinical research center study. J Clin Endocrinol Metab (1995) 1.72
Females secrete growth hormone with more process irregularity than males in both humans and rats. Am J Physiol (1996) 1.66
Endocrine function after spontaneous infarction of the human pituitary: report, review, and reappraisal. Endocr Rev (1980) 1.58
Effects of sex and age on the 24-hour profile of growth hormone secretion in man: importance of endogenous estradiol concentrations. J Clin Endocrinol Metab (1987) 1.58
Reduced disorderliness of growth hormone release in biochemically inactive acromegaly after pituitary surgery. Eur J Endocrinol (1998) 1.56
A feedback-controlled ensemble model of the stress-responsive hypothalamo-pituitary-adrenal axis. Proc Natl Acad Sci U S A (2001) 1.55
Decrease in beta-cell mass leads to impaired pulsatile insulin secretion, reduced postprandial hepatic insulin clearance, and relative hyperglucagonemia in the minipig. Diabetes (2001) 1.54
Testosterone deficiency in young men: marked alterations in whole body protein kinetics, strength, and adiposity. J Clin Endocrinol Metab (1998) 1.51
Altered neuroregulation of GH secretion in viscerally obese premenopausal women. J Clin Endocrinol Metab (2001) 1.45
Enhanced basal and disorderly growth hormone secretion distinguish acromegalic from normal pulsatile growth hormone release. J Clin Invest (1994) 1.42
Synthetic somatostatin analog (octreotide) suppresses daytime growth hormone secretion equivalently in young and older men: preserved pituitary responsiveness to somatostatin's inhibition in aging. J Am Geriatr Soc (1999) 1.41
Dual defects in pulsatile growth hormone secretion and clearance subserve the hyposomatotropism of obesity in man. J Clin Endocrinol Metab (1991) 1.40
Pathophysiology of hypercortisolism in depression. Acta Psychiatr Scand Suppl (2007) 1.40
Synchronicity of frequently sampled, 24-h concentrations of circulating leptin, luteinizing hormone, and estradiol in healthy women. Proc Natl Acad Sci U S A (1998) 1.39
Direct measurement of pulsatile insulin secretion from the portal vein in human subjects. J Clin Endocrinol Metab (2000) 1.38
Fasting enhances growth hormone secretion and amplifies the complex rhythms of growth hormone secretion in man. J Clin Invest (1988) 1.36
Contemporary aspects of discrete peak-detection algorithms. I. The paradigm of the luteinizing hormone pulse signal in men. Endocr Rev (1988) 1.33
Metabolic clearance of biologically active luteinizing hormone in man. J Clin Invest (1986) 1.33
Secretory process regularity monitors neuroendocrine feedback and feedforward signaling strength in humans. Am J Physiol Regul Integr Comp Physiol (2001) 1.32
Stimulation of the growth hormone (GH)-insulin-like growth factor I axis by daily oral administration of a GH secretogogue (MK-677) in healthy elderly subjects. J Clin Endocrinol Metab (1996) 1.31
Abdominal adiposity rather than age and sex predicts mass and regularity of GH secretion in healthy adults. Am J Physiol (1997) 1.31
Biologically active luteinizing hormone is secreted in episodic pulsations that vary in relation to stage of the menstrual cycle. J Clin Endocrinol Metab (1984) 1.27
Short-term estradiol supplementation augments growth hormone (GH) secretory responsiveness to dose-varying GH-releasing peptide infusions in healthy postmenopausal women. J Clin Endocrinol Metab (2001) 1.26
Half-time of endogenous growth hormone (GH) disappearance in normal man after stimulation of GH secretion by GH-releasing hormone and suppression with somatostatin. J Clin Endocrinol Metab (1989) 1.26
Disturbances of the stress response: the role of the HPA axis during alcohol withdrawal and abstinence. Alcohol Health Res World (1998) 1.25
Amplitude modulation of a burstlike mode of cortisol secretion subserves the circadian glucocorticoid rhythm. Am J Physiol (1989) 1.24
Reactivation of pituitary hormone release and metabolic improvement by infusion of growth hormone-releasing peptide and thyrotropin-releasing hormone in patients with protracted critical illness. J Clin Endocrinol Metab (1999) 1.24
Kisspeptin-10 is a potent stimulator of LH and increases pulse frequency in men. J Clin Endocrinol Metab (2011) 1.23
Augmentation of growth hormone secretion during puberty: evidence for a pulse amplitude-modulated phenomenon. J Clin Endocrinol Metab (1987) 1.23
Twenty-four hour cortisol release profiles in patients with Alzheimer's and Parkinson's disease compared to normal controls: ultradian secretory pulsatility and diurnal variation. Neurobiol Aging (1997) 1.22
Hormone pulsatility discrimination via coarse and short time sampling. Am J Physiol (1999) 1.20
Sublingual testosterone replacement improves muscle mass and strength, decreases bone resorption, and increases bone formation markers in hypogonadal men--a clinical research center study. J Clin Endocrinol Metab (1996) 1.17
Bilateral Horner's syndrome secondary to multinodular goiter. Ann Intern Med (1986) 1.15
Rapid changes of prolactinoma volume after withdrawal and reinstitution of bromocriptine. J Clin Endocrinol Metab (1981) 1.14
Sex differences in circulating human leptin pulse amplitude: clinical implications. J Clin Endocrinol Metab (1998) 1.12
Unequal impact of short-term testosterone repletion on the somatotropic axis of young and older men. J Clin Endocrinol Metab (2002) 1.11
Altered neuroendocrine regulation of gonadotropin secretion in women distance runners. J Clin Endocrinol Metab (1985) 1.11
Sex-dependent alteration in cortisol response to endogenous adrenocorticotropin. J Clin Endocrinol Metab (1993) 1.10
An amplitude-specific divergence in the pulsatile mode of growth hormone (GH) secretion underlies the gender difference in mean GH concentrations in men and premenopausal women. J Clin Endocrinol Metab (1996) 1.10
Relationship between age, percentage body fat, fitness, and 24-hour growth hormone release in healthy young adults: effects of gender. J Clin Endocrinol Metab (1994) 1.10
Impact of acute exercise intensity on pulsatile growth hormone release in men. J Appl Physiol (1985) (1999) 1.09
Patients with Cushing's disease secrete adrenocorticotropin and cortisol jointly more asynchronously than healthy subjects. J Clin Endocrinol Metab (1998) 1.08
Short-term estradiol replacement in postmenopausal women selectively mutes somatostatin's dose-dependent inhibition of fasting growth hormone secretion. J Clin Endocrinol Metab (2001) 1.07
Temporal structure of in vivo growth hormone secretory events in humans. Am J Physiol (1991) 1.06
Exercise training at and above the lactate threshold in previously untrained women. Int J Sports Med (1992) 1.06
Contemporary aspects of discrete peak-detection algorithms. II. The paradigm of the luteinizing hormone pulse signal in women. Endocr Rev (1992) 1.06
Corticotropin secretory dynamics in humans under low glucocorticoid feedback. J Clin Endocrinol Metab (2001) 1.05
Sex steroids, growth hormone, insulin-like growth factor-1: neuroendocrine and metabolic regulation in puberty. Horm Res (1996) 1.05
Augmented growth hormone (GH) secretory burst frequency and amplitude mediate enhanced GH secretion during a two-day fast in normal men. J Clin Endocrinol Metab (1992) 1.05
A paradoxical gender dissociation within the growth hormone/insulin-like growth factor I axis during protracted critical illness. J Clin Endocrinol Metab (2000) 1.04
Effects of transdermal testosterone gel on bone turnover markers and bone mineral density in hypogonadal men. Clin Endocrinol (Oxf) (2001) 1.04
Amplitude, but not frequency, modulation of adrenocorticotropin secretory bursts gives rise to the nyctohemeral rhythm of the corticotropic axis in man. J Clin Endocrinol Metab (1990) 1.02
Twenty-four-hour rhythms in plasma concentrations of adenohypophyseal hormones are generated by distinct amplitude and/or frequency modulation of underlying pituitary secretory bursts. J Clin Endocrinol Metab (1990) 1.02
Estimation of daily cortisol production and clearance rates in normal pubertal males by deconvolution analysis. J Clin Endocrinol Metab (1993) 1.02
Tetrabenazine has properties of a dopamine receptor antagonist. Ann Neurol (1982) 1.02
Appraising the nature of luteinizing hormone secretory events in men. Am J Physiol (1987) 1.01
Development of a method for the determination of pulsatile growth hormone secretion in mice. Endocrinology (2011) 1.01
Actions of estrogen on pulsatile, nyctohemeral, and entropic modes of growth hormone secretion. Am J Physiol (1999) 1.00
A biomathematical model of time-delayed feedback in the human male hypothalamic-pituitary-Leydig cell axis. Am J Physiol (1998) 1.00
Are estrogens of import to primate/human ovarian folliculogenesis? Endocr Rev (2001) 1.00
Interactive stimulation by luteinizing hormone and insulin of the steroidogenic acute regulatory (StAR) protein and 17alpha-hydroxylase/17,20-lyase (CYP17) genes in porcine theca cells. Endocrinology (2000) 1.00
The somatotropic axis in critical illness: effect of continuous growth hormone (GH)-releasing hormone and GH-releasing peptide-2 infusion. J Clin Endocrinol Metab (1997) 1.00
Joint recovery of pulsatile and basal hormone secretion by stochastic nonlinear random-effects analysis. Am J Physiol (1998) 0.99
Growth hormone (GH) secretion in patients with an inactivating defect of the GH-releasing hormone (GHRH) receptor is pulsatile: evidence for a role for non-GHRH inputs into the generation of GH pulses. J Clin Endocrinol Metab (2001) 0.99
Pulsatile growth hormone release in normal women during the menstrual cycle. Clin Endocrinol (Oxf) (1992) 0.98
Dynamics of 24-hour endogenous cortisol secretion and clearance in primary hypothyroidism assessed before and after partial thyroid hormone replacement. J Clin Endocrinol Metab (1990) 0.98
Thirty-second sampling of plasma growth hormone in man: correlation with sleep stages. J Clin Endocrinol Metab (1991) 0.98
Failure of physiological plasma glucose excursions to entrain high-frequency pulsatile insulin secretion in type 2 diabetes. Diabetes (2000) 0.98
Aging alters feed-forward and feedback linkages between LH and testosterone in healthy men. Am J Physiol (1997) 0.98
Five-day pulsatile gonadotropin-releasing hormone administration unveils combined hypothalamic-pituitary-gonadal defects underlying profound hypoandrogenism in men with prolonged critical illness. J Clin Endocrinol Metab (2001) 0.98
Maturation of spontaneous and agonist-induced uterine contractions in the peripartum mouse uterus. Biol Reprod (1999) 0.98
Catecholamine release, growth hormone secretion, and energy expenditure during exercise vs. recovery in men. J Appl Physiol (1985) (2000) 0.97
Two-week pulsatile gonadotropin releasing hormone infusion unmasks dual (hypothalamic and Leydig cell) defects in the healthy aging male gonadotropic axis. Eur J Endocrinol (1999) 0.97
Jointly amplified basal and pulsatile growth hormone (GH) secretion and increased process irregularity in women with anorexia nervosa: indirect evidence for disruption of feedback regulation within the GH-insulin-like growth factor I axis. J Clin Endocrinol Metab (1999) 0.97
24-hour pulsatile and circadian patterns of cortisol secretion in alcoholic men. J Androl (1989) 0.96
Development of a methodology for and assessment of pulsatile luteinizing hormone secretion in juvenile and adult male mice. Endocrinology (2013) 0.96
Endurance training amplifies the pulsatile release of growth hormone: effects of training intensity. J Appl Physiol (1985) (1992) 0.96
Short-term modulation of the androgen milieu alters pulsatile, but not exercise- or growth hormone (GH)-releasing hormone-stimulated GH secretion in healthy men: impact of gonadal steroid and GH secretory changes on metabolic outcomes. J Clin Endocrinol Metab (1997) 0.96
Neuroendocrinology of prolonged critical illness: effects of exogenous thyrotropin-releasing hormone and its combination with growth hormone secretagogues. J Clin Endocrinol Metab (1998) 0.95
Hypothesis testing of the aging male gonadal axis via a biomathematical construct. Am J Physiol Regul Integr Comp Physiol (2001) 0.95
Amplified nocturnal luteinizing hormone (LH) secretory burst frequency with selective attenuation of pulsatile (but not basal) testosterone secretion in healthy aged men: possible Leydig cell desensitization to endogenous LH signaling--a clinical research center study. J Clin Endocrinol Metab (1995) 0.95